4D Brain-Targeting Nanomedicines for Treating Neurodegeneration
Aging, Aging, genetic, and environmental factors have increased the prevalence of patients with neurodegenerative brain conditions, with limited treatment modalities. One prerequisite for effective brain treatments is the ability...
Aging, Aging, genetic, and environmental factors have increased the prevalence of patients with neurodegenerative brain conditions, with limited treatment modalities. One prerequisite for effective brain treatments is the ability to target next-generation medications, including RNA and protein drugs, to specific neurons and brain regions. Nanotechnology platforms offer new therapeutic avenues for targeting drugs to organs and cells; their implementation in neurodegenerative diseases is nascent. In this research program, we aim to advance far beyond the state-of-the-art and elucidate the molecular and structural characteristics for designing nanotechnology drugs that target and treat brain neurodegeneration. In preliminary studies, we show that the blood-brain-barrier (BBB) overexpresses disease-specific receptors during neurodegeneration, which enable targeted nanoparticles to cross the BBB and penetrate neurons. Albeit these findings, the magnitude, mechanism, and nanotechnological molecular pattern for brain targeting are lacking. To address this fundamental gap, we will use advanced computation and engineering concepts to develop 4D-brain-targeting nanoparticles, that cross the BBB intact to target specific neuronal populations and brain regions. Robotic synthesis, coupled with active learning algorithms will be used to construct nanoparticles with combinations of targeting moieties on their surface and evaluate their neuronal specificity. Supported microfluidic BBB apparatus will be used to screen the nanoparticles’ ability to target and cross the BBB. A track-and-seek radar system will locate the nanoparticles in the brain, directing localized robotic biopsy of the nanoparticles in the destination cells in the brain. To connect our findings to future clinical implementation, fMRI will be used to record the therapeutic activity of the nanoparticles in the brain. This program will provide the community with essential findings to allow brain-targeted therapeutics.ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.